Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results

This study was conducted to investigate the feasibility and survival benefits of combined treatment with radiotherapy and temozolomide (TMZ), which has been covered by the national health insurance in Japanese patients with glioblastoma since September 2006. Between September 2006 and December 2011,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Oike, Takahiro, Suzuki, Yoshiyuki, Sugawara, Ken-ichi, Shirai, Katsuyuki, Noda, Shin-ei, Tamaki, Tomoaki, Nagaishi, Masaya, Yokoo, Hideaki, Nakazato, Yoichi, Nakano, Takashi
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3827088/
https://ncbi.nlm.nih.gov/pubmed/24265731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0078943
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki